CD22 is a BCR co-receptor that regulates B cell signaling, proliferation and survival and is required for T cell-independent Ab responses. To investigate the role of CD22 during T celldependent (TD) Ab responses and memory B cell formation, we analyzed Ag-specific B cell responses generated by wild-type (WT) or CD22 -/-B cells following immunization with a TD 
Introduction
The B cell-associated receptor, CD22, binds to alpha 2,6-galactose-linked sialic acids that are widely expressed throughout the body. CD22 has a number of ascribed functions including inhibition of BCR signaling via recruitment of SHP-1 phosphatase, as well as facilitation of adhesion between B cells and other cell types [1] . CD22 also regulates B cell homeostasis, survival and migration, and dampens TLR and CD40 signaling [2] [3] [4] CD22-deficient (CD22 -/-) mice have reduced numbers of splenic marginal zone B cells [5, 6] and display defective antibody (Ab) responses to T cell-independent (TI) antigens (Ags) [6] [7] [8] .
It remains unclear to what extent CD22 regulates the development of T cell-dependent (TD) Ab responses and memory B cell formation. Initial studies from our lab and others concluded that CD22 -/-mice have normal responses to TD Ags [6] [7] [8] ; however, mice were evaluated for only up to 35 days following immunization, and secondary Ag challenges were administered before primary immune responses had subsided. Ligands for CD22 have been identified on CD22 itself, IgM, and on T cells [9] [10] [11] . CD22 engagement in trans with CD22 ligands on T cells may regulate T cell activation [12, 13] . Mice unable to express CD22 ligands (ST6GalI -/-mice) have normal T cells but defective TD Ab responses to Ag + adjuvant or influenza infection [14, 15] . Finally, in addition to inhibition of BCR signaling through surface IgM and IgD [6] [7] [8] , CD22 also affects intracellular free calcium released by B cells expressing IgG [16, 17] . Thus, multiple possibilities exist where CD22-CD22L interactions may influence TD B cell responses.
To further investigate the role of CD22 in TD Ab responses and memory B cell formation, we crossed CD22 -/-mice with B1-8 hi knockin mice expressing a VH gene that, when paired with a lambda1 L chain, generates a BCR with high affinity for the hapten, 4(hydroxy-3-nitrophenyl)acetyl (NP) [18] . Although CD22 -/-B1-8 hi B cells were able to respond to immunization with TD Ag and develop into germinal center (GC) B cells, they were not able to differentiate efficiently into memory B cells or long-lived plasma cells (LLPCs) and did not sustain Ab levels over time. We found that the lack of GC output correlated with a failure of CD22 -/-B cells to develop a subset of GC B cells delineated by CXCR4 and CD38 expression.
These results suggest that CD22 plays an important role during TD Ab responses to generate a subset of GC B cells that may represent GC-derived precursors of memory B cells and LLPCs.
Results and discussion
Previous studies have reported that CD22 -/-mice mount normal primary Ab responses to TD antigens [6] [7] [8] , yet establishment of long-term humoral immunity was not reported. (Fig 1D) . Similar results were seen at day 42 and 60 p.i. (Fig 1E) . We obtained similar results when WT and CD22 -/-B cells were transferred into separate recipients. WT B cells detected at these later time points were indeed memory B cells because they expressed multiple surface markers associated with memory B cells (CD38, CD80, CD95 and PD-L2) (Fig 1F) [19] and rapidly expanded upon rechallenge with soluble Ag (Fig 1G) (data are from re-challenge at 125 days p.i). We conclude from these results that CD22-deficient B cells were unable to populate the memory B cell or LLPC pools under the conditions tested. CD22-deficient B cells have decreased survival compared to their WT counterparts [8] . Although CD22 -/-B cells mounted normal early TD Ab responses, it was possible that decreased survival prevented extensive B cell expansion and GC differentiation. To examine these possibilities, co-transfers and immunizations were performed as above and NP-binding B cells were analyzed by flow cytometry 7 days p.i. Both WT and CD22 -/-NP-binding B cells expanded to similar frequencies (Fig 2A and 2B) . Surprisingly, we also observed similar frequencies of WT and CD22 -/-NP-binding B cells that expressed the GC-associated markers GL7 and CD95 (Fig 2C and 2D ). Lastly, we found similar frequencies of apoptotic cells among NP + GL7 + CD22 -/-and WT B cells 7 days p.i. (Fig 2E and 2F) . These results suggest the defect in CD22 -/-B cells is not due to decreased survival or a failure to develop GCs. We conclude that CD22 -/-B cells undergo expansion and GC differentiation comparable to WT B cells.
The fact that CD22 -/-B cells underwent apparent normal GC differentiation yet failed to generate memory B cells or LLPCs implies that selection or development of memory B cell precursors within GCs may be dysregulated in the absence of CD22. The prevailing model of selection within GCs encompasses cyclic recycling whereby GC B cells undergo reiterative CXCR4-dependent cycling between GC light zones (LZ), where they acquire Ag from FDCs, and dark zones (DZ), where they undergo proliferation and somatic hypermutation. To investigate GC sub-populations more closely, we analyzed GC B cells 7 days p.i. for CXCR4 and CD86 expression to determine if CD22-deficient B cells were capable of forming both DZ and LZ B cells. We included CD38 in the analysis as an additional marker of B cell subsets since CD38 is found on naïve B cells, early GC precursors and memory B cells, but not GC B cells [20] . Among NP + GL7 + B cells, those deficient in CD22 formed slightly lower but significant (p<0.001) frequencies of CXCR4 lo CD86 hi LZ GC B cells compared to WT B cells (Fig 3A and   3B ). This trend was evident at day 14 p.i. but was not statistically significant. Analysis of CD38 expression on day 7 p.i. revealed that a large fraction (15-30%) of WT GL7 + B cells coexpressed CD38 (Fig 3C and 3D) (Fig 3E) . Surprisingly, CD22 -/-GL7 + B cells had a highly selective and significant decrease (p < 0.0001) in cells co-expressing CXCR4 and CD38 (Fig 3F) . Previous studies have suggested GL7 + CD38 hi B cells represent pre-or very early GC B cells that give rise to both GC-dependent and GC-independent memory B cells [20, 21] formation, we compared GC B cell formation in CD22 -/-mice to WT mice after immunization with NP-CGG and alum. As seen in the adoptive transfer system, NP-specific IgG Ab hi GC B cells in WT and CD22 -/-mice (E) from 2 independent experiments using 4-6 mice per group. Each dot represents an individual animal. hi subset, thus, may be due to an inability to present Ag to CD4 T FH cells. To test this, we co-transferred WT and CD22 -/-splenocytes into recipient mice as above and injected them 6 days p.i. with NP-coupled streptavidin, to which biotinylated I-Ealpha peptide was bound (NP-streptavidin-I-Ealpha). The I-Ealpha peptide, when presented in the context of I-A b is recognized by the Y-Ae mAb [22] . One day later the mice were sacrificed and NPspecific GL7 + B cell subsets (based on CXCR4 and CD38 expression) were analyzed for Ag presentation by flow cytometry using the Y-Ae mAb. Surprisingly, NP-specific GL7 + CD22 -/-B cells if anything were more efficient in presenting pMHCII than their WT counterparts ( Fig  4A and 4B) . Ag presentation required uptake via Ag-specific BCRs because neither non-specific B cells (total B220 + ) nor NP-specific GL7 + B cells from mice that received streptavidin-I-Ealpha (without NP) displayed pMHCII ( Fig 4A) . All four populations of GL7 + NP-specific B cells expressed pMHCII, demonstrating that CD22-deficient GC B cells are fully capable of Ag capture, processing and presentation in the presence of WT B cells at this stage. We conclude from these experiments that competition with WT B cells for Ag capture is not a factor contributing to their reduced numbers. In contrast to our results, a previous study (Onodera et al.) [23] reported that after immunization CD22 -/-B cells, including GC B cells, rapidly expand and generate short-lived AFCs and antibodies. Unlike in our study, the recipient mice used by these investigators were previously immunized with CGG ('carrier primed'). Thus, both CGG-specific Tfh cells and CGG-anti-CGG immune complexes that can be efficiently taken up by FcγR + cells may have contributed to the rapid hyperproliferative and extrafollicular B cell responses they observed, as has been reported [24] . Such hyperproliferation was clearly not evident in the bona fide primary immune responses we measured. In our studies, numbers of total Ag-specific WT and CD22 [25, 26] . Although our studies here do not address SHP-1 recruitment in CD22 -/-GC B cells, they are consistent with the notion that the absence of CD22 leads to decreased SHP-1 recruitment. Unlike SHP-1 deletion, however, GCs are not ablated in the absence of CD22; rather, a small subset of PNA + GC B cells denoted by CXCR4 and CD38 expression fail to develop. These cells appeared early in the immune response (day 3) and accounted for approximately 10% of the total GL7 + B cell population until day 14. Thus, it appears CD22 is required for the generation of this early subset. Cognate interactions between B and T cells are critical for GC initiation and maintenance, and CD22 ligands are expressed on T cells as well as B cells [11, 27] . Interestingly, high affinity ligands for CD22, while present on naïve and memory B cells, are lost on GC B cells [28] . Thus, one attractive possibility is that once CD22 is unmasked prior to i.p. immunization with 50 micrograms NP-CGG precipitated in alum. In some experiments mice were boosted with 20 micrograms soluble NP-CGG in PBS (i.v.). Total spleen cell counts were obtained using a hemocytometer. Frequencies of NP-specific B cells were obtained by flow cytometry for NP-binding B cells.
Reagents
3(hydroxy-4-nitrophenyl)acetyl (NP) (BioSource) was coupled to phycoerythrin (PE), chicken gamma globulin (CGG) or streptavidin (all from Sigma) as we previously described [29] . Biotinylated I-Ealpha peptide was synthesized by Invitrogen and used to generate both NP-streptavidin-I-Ealpha and NP-streptavidin-AF647-I-Ealpha which were prepared and tested in control experiments as described [28] .
Flow cytometry
The following Abs were used to stain splenocytes for flow cytometry: B220-BrilliantViolet(BV) 605 (BioLegend), Ly5.2-AlexaFluor(AF)700, Ly5.1-PE-Cy7, GL7-APC, CD95-biotin, CCR6-biotin, CD38-FITC, CXCR4-PerCP-eFluor710, CD80-FITC, PD-L2-APC, and Y-Aebiotin (all from eBioscience). Biotinylated Abs were detected with streptavidin-coupled BV421 (BioLegend). Additional reagents used for flow cytometry included PNA-FITC and NP-PE. Surface staining was carried out as described [29] . MitoTracker Red (Invitrogen), Annexin V-FITC (eBioscience) and SYTOX Red viability dye (Invitrogen) were used according to manufacturer's instructions. Data were acquired on a LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo software (Treestar, Inc.). ). ELISA and ELI-SPOT procedures were performed as previously described [30] with the exception that standard curves were not generated.
ELISA and ELISPOT

